Bottom line
IHE vs IYH: the short answer
IHE (iShares U.S. Pharmaceuticals ETF) and IYH (iShares U.S. Healthcare ETF) share a meaningful slice of their top holdings — about 43% by weight.
Both charge the same expense ratio (0.37%).
Over five years, IHE returned +9.1% a year vs +7.0% for IYH.
Updated Nov 19, 2026
IHE vs IYH side by side
| IHE | IYH | |
|---|---|---|
| Type | ETF | ETF |
| Fund family | iShares | iShares |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 0.37% | 0.37% |
| Annual cost per $10k | $37 | $37 |
| 10-yr cost on $10k (prospectus) | $468 | $468 |
| Max front load | None | None |
| 12b-1 fee | 0% | 0% |
| 1-yr return | +31.7% | +13.1% |
| 5-yr return (annualized) | +9.1% | +7.0% |
| 10-yr return (annualized) | +6.2% | +9.4% |
| Best quarter | +17.6% | +15.3% |
| Worst quarter | −16.0% | −12.7% |
| Net assets (fund) | $1.1B | $3.6B |
| Number of holdings | 59 | 103 |
| Portfolio turnover | 29% | 3% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | IHE | IYH | Difference |
|---|---|---|---|
| 2025 | +31.7% | +13.1% | +18.6% |
| 2024 | +8.1% | +3.1% | +5.0% |
| 2023 | +1.0% | +2.1% | −1.1% |
| 2022 | −4.8% | −4.4% | −0.4% |
| 2021 | +12.8% | +23.4% | −10.6% |
| 2020 | +13.8% | +15.5% | −1.7% |
| 2019 | +15.5% | +20.8% | −5.3% |
| 2018 | −7.7% | +5.9% | −13.5% |
| 2017 | +10.7% | +22.3% | −11.6% |
| 2016 | −11.7% | −2.8% | −8.9% |
Source: Fund prospectus bar charts
Holdings overlap
6 of IHE's top 25 holdings also appear in IYH's top 25.
| Holding | IHE | IYH |
|---|---|---|
| Johnson & Johnson | 22.44% | 10.17% |
| Eli Lilly And Company | 22.25% | 15.11% |
| BlackRock Funds III: BlackRock Cash Funds: Institutional; SL Agency Shares | 6.24% | 0.80% |
| Merck & Co., Inc. | 4.55% | 5.31% |
| Bristol-myers Squibb Company | 4.37% | 2.20% |
| Pfizer Inc. | 3.96% | 2.35% |
Source: SEC Form N-PORT
IHE top 10
- Johnson & Johnson — 22.44%
- Eli Lilly And Company — 22.25%
- BlackRock Funds III: BlackRock Cash Funds: Institutional; SL Agency Shares — 6.24%
- Merck & Co., Inc. — 4.55%
- Bristol-myers Squibb Company — 4.37%
- Royalty Pharma Plc — 4.34%
- Viatris Inc. — 4.22%
- Pfizer Inc. — 3.96%
- Zoetis Inc. — 3.73%
- Jazz Pharmaceuticals Public Limited Company — 3.45%
IYH top 10
- Eli Lilly And Company — 15.11%
- Johnson & Johnson — 10.17%
- Abbvie Inc. — 7.32%
- Unitedhealth Group Incorporated — 6.16%
- Merck & Co., Inc. — 5.31%
- Thermo Fisher Scientific Incorporated — 3.52%
- Amgen Inc. — 3.42%
- Abbott Laboratories — 3.02%
- Gilead Sciences, Inc. — 2.66%
- Pfizer Inc. — 2.35%
FAQ
What is the difference between IHE and IYH?
Which is cheaper, IHE or IYH?
Should I own both IHE and IYH?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.